Title : Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.

Pub. Date : 2004 May 25

PMID : 15159506






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a preliminary open trial with FK506, immunosuppressant and enhancer of RyR-related sarcoplasmic calcium release, the authors observed the sustained benefits in anti-RyR-positive MG patients. Tacrolimus ryanodine receptor 1 Homo sapiens